Home › NDC Lookup › RxCUI directory › RxCUI 2169311

{28 (alpelisib 200 MG Oral Tablet) } Pack — RxCUI 2169311

Name: {28 (alpelisib 200 MG Oral Tablet) } Pack (RxCUI 2169311)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Generic pack

RxCUI 2169311 Generic pack · GPCK ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2169311

Official name{28 (alpelisib 200 MG Oral Tablet) } Pack

Concept typeGeneric pack (GPCK)

RxNorm statusCurrent RxNorm concept

Also known asalpelisib 200 MG Oral Tablet, 200 MG Daily Dose Pack; alpelisib 200 MG (28) Oral Tablet, 200 MG Daily Dose Pack

FDA products mapped3

Package NDCs mapped5

Reported Medicaid activity (SDUD)118 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alpelisib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

They treat different conditions, even though they contain the same active ingredient. Piqray is for adults with a specific type of advanced breast cancer — one that is hormone rece...
What exactly is alpelisib treating — is it the same condition for Piqray and Vijoice?
Yes, you should always take alpelisib with food — this meaningfully increases how much of the drug your body absorbs. The good news is that clinical data show no significant differ...
Do I have to take this with food, and does it matter what kind of food?

📖 Read our full Alpelisib guide →

🕸️ Concept Web — How {28 (alpelisib 200 MG Oral Tablet) } Pack Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept {28 (alpelisib 200 MG Oral Tablet) } Pack RxCUI 2169311 Generic pack · GPCK

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Alpelisib 2169285 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Piqray 2169302 BN
- Vijoice 2598454 BN
Dose forms 12

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Alpelisib Oral Tablet 2169299 SCDF
- Alpelisib Oral Product 2169297 SCDG
- Alpelisib Pill 2169298 SCDG
- Alpelisib Oral Tablet [Piqray] 2169304 SBDF
- Alpelisib Oral Tablet [Vijoice] 2598458 SBDF
- Piqray Oral Product 2169305 SBDG
- Piqray Pill 2169306 SBDG
- Vijoice Oral Product 2598456 SBDG
- +4 more in this family
Clinical & branded drugs 6

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Alpelisib 200 MG Oral Tablet 2169310 SCD
- Alpelisib 200 MG 2169309 SCDC
- Alpelisib 200 MG Oral Tablet [Piqray] 2169313 SBD
- Alpelisib 200 MG Oral Tablet [Vijoice] 2598469 SBD
- Alpelisib 200 MG [Piqray] 2169312 SBDC
- Alpelisib 200 MG [Vijoice] 2598468 SBDC
Packs 1

Fixed collections of drugs packaged and sold together, like dose packs.
- {28 (alpelisib 200 MG Oral Tablet [Piqray]) } Pack [Piqray 200 MG Daily Dose] 2169314 BPCK

Showing up to 8 concepts per family — 18 of 22 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Alpelisib 200 MG Oral Tablet SCD · 2169310
Alpelisib 200 MG SCDC · 2169309
Alpelisib Oral Tablet SCDF · 2169299
Alpelisib Oral Product SCDG · 2169297
Alpelisib Pill SCDG · 2169298

Brand-Name Concepts

Alpelisib 200 MG Oral Tablet [Piqray] SBD · 2169313
Alpelisib 200 MG Oral Tablet [Vijoice] SBD · 2598469
{28 (alpelisib 200 MG Oral Tablet [Piqray]) } Pack [Piqray 200 MG Daily Dose] BPCK · 2169314
Alpelisib 200 MG [Piqray] SBDC · 2169312
Alpelisib 200 MG [Vijoice] SBDC · 2598468
Alpelisib Oral Tablet [Piqray] SBDF · 2169304
Alpelisib Oral Tablet [Vijoice] SBDF · 2598458
Piqray Oral Product SBDG · 2169305
Piqray Pill SBDG · 2169306
Vijoice Oral Product SBDG · 2598456

📦 FDA Products & Package NDCs

3 products · 5 package NDCs

5 package NDCs map to RxCUI 2169311 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00078-0701-84	1 BLISTER PACK in 1 CARTON (0078-0701-84) / 28 TABLET in 1...	PIQRAY	Novartis Pharmaceuticals Corporation	2019-05-24
00078-0708-02	2 BLISTER PACK in 1 CARTON (0078-0708-02) / 28 TABLET in 1...	PIQRAY	Novartis Pharmaceuticals Corporation	2019-05-24
00078-0708-91	1 BLISTER PACK in 1 CARTON (0078-0708-91) / 28 TABLET in 1...	PIQRAY	Novartis Pharmaceuticals Corporation	2019-05-24
00078-0715-02	2 KIT in 1 CARTON (0078-0715-02) / 1 KIT in 1 KIT (0078-071...	PIQRAY	Novartis Pharmaceuticals Corporation	2019-05-24
00078-0715-91	1 KIT in 1 CARTON (0078-0715-91) / 1 KIT in 1 KIT (0078-071...	PIQRAY	Novartis Pharmaceuticals Corporation	2019-05-24

Observed labelers: Novartis Pharmaceuticals Corporation (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.